ATE183100T1 - NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC, ANTIVIRAL AND ANTIMETASTATIC AGENTS - Google Patents

NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC, ANTIVIRAL AND ANTIMETASTATIC AGENTS

Info

Publication number
ATE183100T1
ATE183100T1 AT92904197T AT92904197T ATE183100T1 AT E183100 T1 ATE183100 T1 AT E183100T1 AT 92904197 T AT92904197 T AT 92904197T AT 92904197 T AT92904197 T AT 92904197T AT E183100 T1 ATE183100 T1 AT E183100T1
Authority
AT
Austria
Prior art keywords
antidiabetic
antiviral
novel
inhibitors useful
pct
Prior art date
Application number
AT92904197T
Other languages
German (de)
Inventor
Robert A Farr
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE183100T1 publication Critical patent/ATE183100T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/567—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with sulfur as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

PCT No. PCT/US91/09387 Sec. 371 Date Dec. 9, 1993 Sec. 102(e) Date Dec. 9, 1993 PCT Filed Dec. 13, 1991 PCT Pub. No. WO92/11867 PCT Pub. Date Jul. 23, 1992.The invention provides the compounds 1,2-dideoxy-2-(hydroxymethyl)-1-(methylamino)-myo-inositol hydrochloride, 1,2-dideoxy-2-(hydroxymethyl)-1-(methylamino)-scyllo-inositol, 1,6-dideoxy-6-(hydroxymethyl)-1-(methylamino)-myo-inositol.
AT92904197T 1991-01-10 1991-12-13 NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC, ANTIVIRAL AND ANTIMETASTATIC AGENTS ATE183100T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63963591A 1991-01-10 1991-01-10
US78420891A 1991-10-28 1991-10-28

Publications (1)

Publication Number Publication Date
ATE183100T1 true ATE183100T1 (en) 1999-08-15

Family

ID=27093368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904197T ATE183100T1 (en) 1991-01-10 1991-12-13 NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC, ANTIVIRAL AND ANTIMETASTATIC AGENTS

Country Status (15)

Country Link
US (1) US5438069A (en)
EP (1) EP0566666B1 (en)
JP (1) JP2951723B2 (en)
KR (1) KR100192862B1 (en)
AT (1) ATE183100T1 (en)
AU (1) AU660641B2 (en)
CA (1) CA2098927A1 (en)
DE (1) DE69131522T2 (en)
DK (1) DK0566666T3 (en)
ES (1) ES2136615T3 (en)
GR (1) GR3031423T3 (en)
IE (1) IE920087A1 (en)
NZ (1) NZ241234A (en)
PT (1) PT100001B (en)
WO (1) WO1992011867A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003903A1 (en) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205068A (en) * 1978-05-18 1980-05-27 E. R. Squibb & Sons, Inc. β-Lactamase inhibitor EM4615
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
US4399224A (en) * 1981-07-13 1983-08-16 A. E. Staley Manufacturing Company Enzymatically treated phosphatides
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4622295A (en) * 1982-09-16 1986-11-11 Wako Pure Chemical Industries, Ltd. Modified oligosaccharides used as substrate for measuring α-amylase activity
ES2058070T3 (en) * 1986-05-09 1994-11-01 Pulverer Gerhard USE OF SPECIFIC MONOSACCHARIDES FOR THE PREPARATION OF A MEDICINAL PRODUCT TO PREVENT METASTASIS OF MALIGNANT TUMORS.
US4963479A (en) * 1986-10-07 1990-10-16 Hoechst Celanese Corporation Reagent system for an alpha-amylase assay containing aromatic substituted glycoside
US4962097A (en) * 1988-10-28 1990-10-09 Merck & Co., Inc. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors

Also Published As

Publication number Publication date
DE69131522D1 (en) 1999-09-16
IE920087A1 (en) 1992-07-15
PT100001B (en) 1999-06-30
NZ241234A (en) 1994-07-26
JPH06504550A (en) 1994-05-26
AU9176091A (en) 1992-08-17
DE69131522T2 (en) 1999-11-25
EP0566666A4 (en) 1994-06-08
DK0566666T3 (en) 1999-12-06
ES2136615T3 (en) 1999-12-01
WO1992011867A1 (en) 1992-07-23
PT100001A (en) 1993-02-26
KR100192862B1 (en) 1999-06-15
KR930703013A (en) 1993-11-29
GR3031423T3 (en) 2000-01-31
AU660641B2 (en) 1995-07-06
EP0566666A1 (en) 1993-10-27
JP2951723B2 (en) 1999-09-20
EP0566666B1 (en) 1999-08-11
US5438069A (en) 1995-08-01
CA2098927A1 (en) 1992-07-11

Similar Documents

Publication Publication Date Title
SE9604793D0 (en) New polymorphs
DE69431194D1 (en) AMIDINO DERIVATIVES USEFUL AS NO SYNTHASE INHIBITORS
TR199801255T2 (en) Vitronectin receptor antagonists.
DK0772610T3 (en) dihydrobenzofuranes
BR9611175A (en) Compounds or their compositions and use thereof
DK0544819T3 (en) Indole derivatives which inhibit leukotriene biosynthesis
DE69621831D1 (en) PIPERAZINE DERIVATIVES AS TACHYKININ ANTAGONISTS
ITMI931780A1 (en) TROPIL 7-AZAINDOLIL-3-CARBOXYAMIDE
DK0937074T3 (en) Benzonaphthyridines as bronchial therapeutics
ATE233252T1 (en) SUBSTITUTED DIHYDROBENZOFURANES AS PDE INHIBITORS
PT920426E (en) NEW TIAZOLE DERIVATIVES WITH PHOSPHODIESTERASE INHIBITOR EFFECT
FI973221A0 (en) 1-Aryl-2-acylaminoethane compounds and their use as neurokinin antagonists, in particular as neurokinin 1 antagonists
DE69131522D1 (en) INNOVATIVE GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC, ANTIVIRAL AND ANTIMETASTATIC AGENTS
DK0689575T3 (en) Anthraquinones as marking agents for mineral oils
BG100248A (en) SQUALENSENTEZA INHIBITORS
NO307462B1 (en) Imidazopyridine azolidinoner
TR199701298T1 (en) Tetralins.
FR2707990B1 (en) New nitrones usable for trapping free radicals.
NO941084D0 (en) Neuroleptic 2-substituted perhydro-1-H-pyrido [1,2-alpha-pyrazines
ES2091039T3 (en) NEW BIS-FENIL-HEXENOS.
FI962301A0 (en) Substituted aminoalkylamine pyridines
NO950723D0 (en) Optically active hydroquinin 1- (3-aminophenyl) ethanesulfonate, its preparation and use
ECSP972052A (en) QUINOXALINADIONAS
DE59911958D1 (en) Fluorinated 3,4-dihydropinoline derivates as Nos-inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee